Bryce Point Capital’s Tenet Healthcare THC Stock Holding History

Bryce Point Capital’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,884	Closed	-$490K	–	423
2024 Q4	$490K	Buy	+3,884	New	+$578K	0.14%	304

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bryce Point Capital's THC Position: Q1 2025 in Review

Bryce Point Capital sold out of Tenet Healthcare (THC) in Q1 2025, closing a stake of 3,884 shares — an estimated $490K sold.

Bryce Point Capital first reported a position in THC in Q4 2024 and held it in 1 quarter. The position peaked at $490K in Q4 2024. 566 funds tracked by Wall St. Rank hold THC as of Q1 2025.

Bryce Point Capital reported no remaining Tenet Healthcare position as of Q1 2025 after selling out during the quarter.
Bryce Point Capital sold 3,884 Tenet Healthcare shares in Q1 2025, an estimated $490K.
Bryce Point Capital first reported a position in Tenet Healthcare in Q4 2024 and held it in 1 quarter.
Bryce Point Capital's Tenet Healthcare position peaked at $490K in Q4 2024.
566 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2025.

Based on Bryce Point Capital's 13F filing for Q1 2025, filed 7 May 2025.